Back to Agenda
Leveraging Wearables and Sensors in Clinical Trials: Case Studies
Session Chair(s)
Michael Phinney, MBA
Engagement Leader
QuintilesIMS, United States
Due to the increased miniaturization of sensors and circuitry, the health and wellness industry is seeing rapid proliferation in the number and diversity of wearables and sensors to provide personal wellness applications. This provides opportunity to collect greater and richer data during clinical trials and post-marketing studies, and also to develop beyond the pill strategies to support launching or marketing products.
This session explores the impact of wearables and sensors on clinical trial conduct and participation. We also consider how to ensure the validity and acceptability of health outcomes that are derived from wearables data. Finally, we consider how pharma is levering wearables and sensors to deliver beyond the pill strategies to support patients and physicians in the effective use of their treatments.
Learning Objective : Describe the impact of wearables and sensors on clinical trial conduct and participation; Identify how pharma is leveraging wearables; Discuss the importance of validity and acceptability of the data from wearables.
Speaker(s)
How Can Wearables Improve Patient Care and Enhance Research in Autoimmune Diseases?
Michael Phinney, MBA
QuintilesIMS, United States
Engagement Leader
Mobile Accelerometry in Clinical Trials: Towards Regulatory Decision Making
Martin Daumer, DrSc
Sylvia Lawry Centre For Multiple Sclerosis Research - The Human Motion Institute, Germany
Scientific Director
Novel Technology for Continuous Arrhythmia Monitoring: The Role in Assessing CV Arrhythmic Safety
Richard Clark
Clark Life Science Consulting LLC, United States
Consultant
Have an account?